Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2008
10/02/2008US20080241894 Vector constructs
10/02/2008US20080241891 Method for the Amplification and Detection of HBV DNA Using a Transcription Based Amplification
10/02/2008US20080241890 Total integration of all substances and process steps is achieved in closed, single-use unit in which reagents are stored in storage-stable form at room temperature; water-soluble reagents are covered by water-insoluble medium, DNA is supplied and water-insoluble medium is eliminated, so pcr can start
10/02/2008US20080241889 Expression vector for use in recombinational cloning
10/02/2008US20080241887 Glycoamylase for use in enhanced brewing, production of glucose and/or high fructose syrups and fermentation of fuel and/or drinking ethanol
10/02/2008US20080241883 Enhanced nucleotide sequences for transfer and expression immunoglobulin fusions in cells
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241872 Using cold and menthol-sensitive receptor (CMR1) polypeptide as diagnostic tool in identifying modulators for treatment of pain and cold sensitivity
10/02/2008US20080241867 Expression vector comprising nucleotide sequences coding reporter protein/protease cleavage sequence fusion; detecting enzymatic activity in solution
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241833 Using primer extension to determine sequence of single nucleotide polymorphism; gene expression analysis
10/02/2008US20080241830 Using serial dilution and cyclic aplification to detect mutant cancer-associated sequences in healthy cell populations
10/02/2008US20080241826 Probe And Primer For Tubercle Bacillus Detection, And Method Of Detecting Human Tubercle Bacillus Therewith
10/02/2008US20080241825 Materials and Methods for Treatment of Cancer
10/02/2008US20080241347 Modulating plant carbon levels
10/02/2008US20080241341 Expression vector for transforming soybean and controlled transcription of heterologous nucleotide sequences; animal feeds; nutraceuticals
10/02/2008US20080241340 Oil enhancing genes; diacylglycerol acyltransferase, phosphatidic acid phosphatase, and leucoanthocyanidin dioxygenase; transgenic seeds, cells, plants; feeds
10/02/2008US20080241198 Selective angiogenesis and gene expression inhibition of the vascular endothelial growth factor pathway; ocular disease; antiarthritic, antiinflammatory agents
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241193 An expression vector for Leishmania kinetoplastid membrane protein 11 antigen or an epitope thereof, from a recombinant canarypox virus; prime-boost administration regimen; prevents diffusion and implantation of parasite into internal organs
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241181 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241173 Using FLT3 kinase as tool in identifying modulators for treatment and prevention of hematopoietic stem cell disease
10/02/2008US20080241172 Mutated Cholinesterase Sequences, Corresponding Nucleic Acids And Their Uses
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241160 Interleukin-4 specific immunoglobulin for use in treatment and prevention of atopic, respiratory and allergic disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241157 Nerve cell growth modulators (amphibodies)
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241116 Using vector comprising nucleotide sequences coding serine phage intergrase to transfer heterologous nucleotide sequences into cells; inproving exogenous gene expression; gene therapy
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241075 Parasite Vaccine
10/02/2008US20080241069 Methods and compositions for treating IgE-mediated diseases
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008US20080240985 detection of specific nucleic acid sequences, either by a process of amplification of specific nucleic acid sequences or not. More particularly the invention provides for improved compositions and methods for reducing the chance for contamination from manipulation of reagents, internal controls
10/02/2008DE102007015583A1 Ein Enzym zur Herstellung von Methylmalonyl-Coenzym A oder Ethylmalonyl-Coenzym A sowie dessen Verwendung An enzyme for the production of methylmalonyl-coenzyme A or ethylmalonyl-coenzyme A and the use thereof
10/02/2008DE102007015377A1 Verfahren zur Herstellung einer transformierten Zelle A process for preparing a transformed cell
10/02/2008DE102004021780B4 Verfahren und Anordnung zur DNA-Isolierung mit Trockenreagenzien Method and apparatus for DNA isolation with dry reagents
10/02/2008CA2719711A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008CA2688450A1 Microorganisms and methods for production of 1,2-propanediol and acetol
10/02/2008CA2682260A1 Method for measuring dna methylation
10/02/2008CA2682045A1 Method of eliciting immune response with a modified mva viral hiv-1 vector
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681661A1 Methods of increasing nitrogen-assimilation capacity in transgenic plants expressing cca1 and glk1
10/02/2008CA2681621A1 Enhanced amylase production by n-terminal addition to mature amylase protein
10/02/2008CA2681531A1 Immunoglobulin heavy chains comprising heterologous t-cell epitopes
10/02/2008CA2681530A1 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
10/02/2008CA2681517A1 Dsrna compositions and methods for treating hpv infections
10/02/2008CA2681515A1 Transgenic plants with increased stress tolerance and yield expressing a lrp-2 protein
10/02/2008CA2681392A1 Hafnia phytase
10/02/2008CA2681297A1 Method for determination of presence of crossing with cultivated rose in wild rose
10/02/2008CA2681294A1 Method for producing high-purity soluble thrombomodulin
10/02/2008CA2680837A1 Mek ligands and polynucleotides encoding mek ligands
10/02/2008CA2680237A1 Constructs and libraries comprising antibody surrogate light chain sequences
10/02/2008CA2679176A1 Antidesiccant
10/02/2008CA2678919A1 Gene expression signature for classification of cancers
10/02/2008CA2678901A1 Methods for modulating embryonic stem cell differentiation
10/02/2008CA2678698A1 Use of an avirulent bordetella mutant as a live vaccine vector
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/02/2008CA2584758A1 Mix, some of best and novel cloning techniques
10/01/2008EP1975620A2 Three hybrid assay system
10/01/2008EP1975256A1 Modified oligonucleotides for mismatch discrimination
10/01/2008EP1975254A1 Method of detecting nucleotide sequence with an intramolecular probe
10/01/2008EP1975251A2 Real-time sequence determination
10/01/2008EP1975248A1 Nucleotide primer set and nucleotide probe for detecting genotype of methylene tetrahydrofolate reductase (MTHFR)
10/01/2008EP1975239A1 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
10/01/2008EP1975238A1 Gene construct, vector and dna vaccine for the vaccination of aquatic animals
10/01/2008EP1975237A2 Beta-fructofuranosidase and its gene, method of isolating beta-fructofuranosidase gene, system for producing beta-fructofuranosidase, and beta-fructofuranosidase variant
10/01/2008EP1975236A2 Polyhydroxyalkanoate production from polyols
10/01/2008EP1975235A2 Porcine circovirus vaccine in recombinant poxvirus
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975233A1 Nucleic acid binding proteins
10/01/2008EP1975232A1 Yeast and method of producing l-lactic acid
10/01/2008EP1975231A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/01/2008EP1975228A1 Polynucleotides for enhancing expression of a polynucleotide of interest
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975175A2 IgA nephropathy-related DNA
10/01/2008EP1975174A1 Selective peptides that inhibit the biological activity of calcineurin
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors